Target intelligence / Profile preview

5S ribosomal RNA pseudogene 191 (RNA5SP191)

Target
RNA5SP191
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 191 (RNA5SP191) is not a protein-coding gene, but rather a pseudogene of the 5S ribosomal RNA gene, classified as an rRNA pseudogene[4]. RNA5SP191 is a non-functional pseudogene derived from the 5S ribosomal RNA gene. 5S rRNA is an approximately 120 nucleotide-long structural RNA essential for the formation and function of the ribosomal large subunit[3]. Pseudogenes such as RNA5SP191 arise by genomic duplication or retrotransposition but have lost their original function due to accumulated mutations and regulatory defects[2][4]. Therefore, RNA5SP191 does not produce active rRNA and does not participate in normal ribosome assembly or function. Some pseudogenes can have minor regulatory effects in the cell by acting as decoys for microRNAs or RNA-binding proteins, but there is no specific evidence for such activity in RNA5SP191[2]. It is not therapeutically relevant, does not interact with drugs, and is not used clinically. As a summary, RNA5SP191 is a non-coding RNA pseudogene, not a therapeutic target, and does not serve any well-defined biological or disease role. There are no drug interactions, mechanisms of action, biomarkers, or safety concerns associated with it. It is essentially an inactive genetic copy of 5S rRNA with no established function or clinical relevance.

Other names
RN5S191RNA, 5S ribosomal 191RNA5SP191
02

Mechanism of action

None

03

Biological functions

Generally considered non-functional (does not encode functional 5S rRNA)No direct function reported for RNA5SP191Potential minor regulatory role (e.g., miRNA sponging, post-transcriptional gene regulation) if expressed, but negligible and not specifically evidenced for RNA5SP191.
04

Disease associations

Not directly implicated in diseaseNo specific evidence for disease involvement of this pseudogeneMost rRNA pseudogenes are not implicated directly in disease, though some pseudogenes may contribute to cancer or other diseases if abnormally transcribed.
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 191 (RNA5SP191).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 191 (RNA5SP191).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call